This inventor holds 1 USPTO granted patent. Top assignee: Beijing University of Technology. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: The Innovative Contributions of Emma Jones
Introduction
Emma Jones is a prominent inventor based in Melbourne, Australia. She has made significant strides in the field of medical research, particularly in the treatment of fibrosis. Her work has the potential to impact many lives, showcasing her dedication to innovation and healthcare.
Latest Patents
Emma Jones holds a patent for "Angiotensin receptor agonists and uses thereof." This invention relates to compositions, methods, and kits designed for the treatment of fibrosis, specifically cardiac fibrosis. The invention provides a method of treating fibrosis in an individual by administering an AT2R selective agonist, thereby effectively addressing this serious health condition.
Career Highlights
Emma is affiliated with the Beijing University of Technology, where she continues to advance her research and contribute to the scientific community. Her work is characterized by a commitment to developing effective treatments that can improve patient outcomes.
Collaborations
Emma has collaborated with notable colleagues, including Robert Edward Widdop and Marie-Isabel Aguilar. These partnerships have enriched her research and expanded the scope of her innovative projects.
Conclusion
Emma Jones exemplifies the spirit of innovation in the medical field, with her groundbreaking patent addressing a critical health issue. Her contributions are paving the way for future advancements in the treatment of fibrosis.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile